Related Experiment Videos
Clindamycin treatment of experimental chronic osteomyelitis due to Staphylococcus aureus
Abstract:
Clindamycin was used alone for treatment of experimental osteomyelitis due to Staphylococcus aureus in rabbits. Treatment with 30 mg/kg of body weight three times a day for 14 days was ineffective in sterilizing infected rabbit bones. In contrast, when given for 28 days, clindamycin sterilized the infected bones of 16 (84%) of 19 rabbits treated. Only one of 14 isolates of S. aureus from rabbits treated for two weeks developed resistance to clindamycin (minimal inhibitory concentration, greater than 100 micrograms/ml); none of three isolates from rabbits in which treatment failed in the four-week treatment group showed resistance to clindamycin. The results of four weeks of treatment with clindamycin for chronic experimental staphylococcal osteomyelitis were significantly better than those obtained with any other single agent used in prior studies and were generally as good as those with combination therapy that included rifampin.
Insights
Extended clindamycin treatment (28 days) effectively sterilized Staphylococcus aureus osteomyelitis in rabbits, outperforming shorter durations and other single agents. This suggests longer treatment is crucial for eradicating bone infections.
Area of Science:
- Infectious Diseases
- Pharmacology
- Orthopedic Surgery
Background:
- Osteomyelitis, a bone infection often caused by Staphylococcus aureus, presents a significant clinical challenge.
- Current treatment strategies for chronic osteomyelitis, including antibiotic therapy, have varying success rates.
- The efficacy of clindamycin in treating experimental Staphylococcus aureus osteomyelitis requires further investigation.
Purpose of the Study:
- To evaluate the effectiveness of clindamycin in treating experimental osteomyelitis caused by Staphylococcus aureus in a rabbit model.
- To compare the outcomes of 14-day versus 28-day clindamycin treatment regimens.
- To assess the development of antibiotic resistance during clindamycin therapy.
Main Methods:
- Rabbits with experimentally induced Staphylococcus aureus osteomyelitis were treated with clindamycin at 30 mg/kg three times daily.
- Two treatment durations were employed: 14 days and 28 days.
- Bacterial cultures and minimal inhibitory concentration (MIC) testing were performed on isolates from treated rabbits.
Main Results:
- A 14-day treatment course of clindamycin was ineffective in sterilizing infected bones.
- A 28-day treatment course sterilized infected bones in 84% of rabbits (16 out of 19).
- Antibiotic resistance to clindamycin was minimal, with only one isolate showing resistance after 14 days of treatment.
Conclusions:
- Extended treatment duration (28 days) of clindamycin is significantly more effective than shorter durations (14 days) for experimental Staphylococcus aureus osteomyelitis.
- Clindamycin monotherapy for 28 days demonstrated comparable efficacy to combination therapies in previous studies.
- Longer clindamycin treatment courses appear to be a viable strategy for managing chronic staphylococcal osteomyelitis with a low risk of resistance development.